Purpose
To provide access to mRNA technology to Development Country Vaccine Manufacturers to enable them to develop and manufacture mRNA vaccines for the low-and medium-income countries.
Grantee
Division
Global Health
Date
NOVEMBER 2023
Region served
GLOBAL
Committed amount
$20,192,073
Grant topic
Vaccine Development
Duration (months)
35
Grantee location
Nivelles, Belgium
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.